Clinical and imaging data from 27 glioblastoma patients and 30 individuals with brain metastases were analyzed, measuring and comparing their intra-tumoral and sera MMP-9 levels and activity against those of 12 meningioma patients and 23 healthy controls. This evidence concerns the gene MMP9 and meningioma.